Boehringer Ingelheim USA Corporation

Newcastle University, University of Edinburgh, and Boehringer Ingelheim secured funding for a major liver cirrhosis study. University of New England received NIH support for the UNE Center for Cell Signaling Research. Oxitope Pharma and Arxx Therapeutics merged into Calluna Pharma Inc., focusing on antibodies for inflammatory and fibrotic conditions.

Biosimilars, similar to biologics in safety and efficacy, face complex production challenges. Regulatory frameworks vary globally, with the EU leading in biosimilar approvals. Biosimilars offer cost savings, with significant market growth expected as biologics' patents expire. The U.S. and EU are key markets, with biosimilars projected to save billions in healthcare costs.